{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:13:21Z","timestamp":1793884401596,"version":"4.7.0"},"reference-count":29,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10390012110044"],"award-info":[{"award-number":["10390012110044"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,7,30]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Muscle-invasive bladder cancer (MIBC) is an aggressive type of cancer. About 50% of patients will die from the disease within 5 years despite radical treatment. This implies that in many patients, the disease has already spread at the time of radical treatment, even though imaging shows no signs of metastasis. We hypothesise that the standard local staging method, transurethral resection of the bladder tumour (TURBT), is partly responsible for tumour cell spread. Furthermore, TURBT (and re-TURBT in many patients) contributes to a significant delay to definitive therapy. The aim of this randomised study is to determine whether multiparametric MRI (mpMRI) of the bladder, in combination with a single outpatient bladder tumour biopsy for histological confirmation, is a safer, faster, less costly and, therefore, more cost-effective diagnostic pathway than TURBT to detect or rule out MIBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>BladParadigm is a two-arm multicentre randomised controlled trial (RCT) conducted in the Netherlands. Over a 3-year period, patients with clinically suspected MIBC without evidence of metastases will be recruited and randomised 1:1 to either TURBT or 3-Tesla mpMRI with same-day outpatient bladder biopsy. The Vesical Imaging Reporting and Data System (VI-RADS) will be used to standardise mpMRI reporting. Patients will undergo definitive treatment based on the results of the TURBT or mpMRI. The study is powered to demonstrate that the mpMRI-based strategy is at least non-inferior to standard TURBT in patients treated with radical cystectomy alone, assuming a relative hazard of 0.55. The required sample size is 360 patients (180 TURBT, 180 mpMRI). The primary outcome is 2-year progression-free survival. Progression will be assessed by imaging, according to the current standard of care. Secondary outcome measures are time to definitive treatment, quality of life (EuroQol 5D-5L), healthcare costs and cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study has received ethical approval from the Medical Ethical Committee Oost-Nederland (NL83685.091.23). All participants will provide written informed consent prior to inclusion. Findings of this study will be disseminated through peer-reviewed, open-access publications, presentations at scientific conferences and stakeholder briefings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05779631\">NCT05779631<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-100002","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T07:30:35Z","timestamp":1755415835000},"page":"e100002","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study)"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05779631","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05779631","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5608-397X","authenticated-orcid":false,"given":"Sebastiaan W","family":"van Koeverden","sequence":"first","affiliation":[{"name":"Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa MC","family":"van Hoogstraten","sequence":"additional","affiliation":[{"name":"Department of Urology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"de Rooij","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"van der Leest","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke PC","family":"Grutters","sequence":"additional","affiliation":[{"name":"IQ Health Science Department, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"BladParadigm study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambertus ALM","family":"Kiemeney","sequence":"additional","affiliation":[{"name":"Department of Urology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"},{"name":"IQ Health Science Department, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine G","family":"van der Heijden","sequence":"additional","affiliation":[{"name":"Department of Urology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"2025123106465776000_15.8.e100002.1","unstructured":"Netherlands comprehensive cancer organisation . Netherlands cancer registry (ncr) - bladder cancer 2024. 2024. Available: https:\/\/nkr-cijfers.iknl.nl [Accessed 1 Oct 2024]."},{"key":"2025123106465776000_15.8.e100002.2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2014.06.083","article-title":"Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream","volume":"193","author":"Engilbertsson","year":"2015","journal-title":"J Urol"},{"key":"2025123106465776000_15.8.e100002.3","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14432"},{"key":"2025123106465776000_15.8.e100002.4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2016.03.051","article-title":"Hematogenous Tumor Cell Spread Following Standard Transurethral Resection of Bladder Carcinoma","volume":"70","author":"Blaschke","year":"2016","journal-title":"Eur Urol"},{"key":"2025123106465776000_15.8.e100002.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65969-1"},{"key":"2025123106465776000_15.8.e100002.6","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199907000-00018"},{"key":"2025123106465776000_15.8.e100002.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.12.016"},{"key":"2025123106465776000_15.8.e100002.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67022-X"},{"key":"2025123106465776000_15.8.e100002.9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euo.2019.09.008","article-title":"A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients","volume":"3","author":"Russell","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"2025123106465776000_15.8.e100002.10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017171028"},{"key":"2025123106465776000_15.8.e100002.11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/bju.14366","article-title":"Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis","volume":"122","author":"Gandhi","year":"2018","journal-title":"BJU Int"},{"key":"2025123106465776000_15.8.e100002.12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","article-title":"Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis","volume":"3","author":"Woo","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"2025123106465776000_15.8.e100002.13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2021.02.021","article-title":"Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study","volume":"80","author":"Bryan","year":"2021","journal-title":"Eur Urol"},{"key":"2025123106465776000_15.8.e100002.14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1200\/JCO-25-00779","article-title":"Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial","volume":"43","author":"Bryan","year":"2025","journal-title":"J Clin Oncol"},{"key":"2025123106465776000_15.8.e100002.15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines","volume":"87","author":"van der Heijden","year":"2025","journal-title":"Eur Urol"},{"key":"2025123106465776000_15.8.e100002.16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"2025123106465776000_15.8.e100002.17","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2025123106465776000_15.8.e100002.18","unstructured":"Zorginstituut Nederland . Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg [guideline for conducting economic evaluations in healthcare]. 2024. Available: https:\/\/www.zorginstituutnederland.nl\/publicaties\/publicatie\/2024\/01\/16\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg"},{"key":"2025123106465776000_15.8.e100002.19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s40273-016-0431-y","article-title":"From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare","volume":"34","author":"Versteegh","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"2025123106465776000_15.8.e100002.20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch Tariff for the Five-Level Version of EQ-5D","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Health"},{"key":"2025123106465776000_15.8.e100002.21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W"},{"key":"2025123106465776000_15.8.e100002.22","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4730030505"},{"key":"2025123106465776000_15.8.e100002.23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7956"},{"key":"2025123106465776000_15.8.e100002.24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.30445","article-title":"A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy","volume":"140","author":"Soave","year":"2017","journal-title":"Int J Cancer"},{"key":"2025123106465776000_15.8.e100002.25","doi-asserted-by":"crossref","first-page":"89228","DOI":"10.18632\/oncotarget.19159","article-title":"Impact of preoperative diagnostic TURBT on progression-free survival in patients with pathological high-grade, stage T3\/T4 bladder urothelial carcinoma","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"2025123106465776000_15.8.e100002.26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00345-023-04428-6","article-title":"The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients","volume":"41","author":"van Straten","year":"2023","journal-title":"World J Urol"},{"key":"2025123106465776000_15.8.e100002.27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1308\/rcsann.2016.0246","article-title":"Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours","volume":"98","author":"During","year":"2016","journal-title":"Ann R Coll Surg Engl"},{"key":"2025123106465776000_15.8.e100002.28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1148\/radiol.2019182506","article-title":"Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion","volume":"291","author":"Wang","year":"2019","journal-title":"Radiology"},{"key":"2025123106465776000_15.8.e100002.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06117-8"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-100002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:48:30Z","timestamp":1767192510000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-100002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,16]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjopen-2025-100002"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-100002","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}